Editor’s (re)View: It matters if Big Pharma is fudging its US investment numbers

from Off Script: A Pharma Manufacturing Podcast · host Pharma Manufacturing

Large biopharma companies in recent months have pledged billions of dollars in capital expenditures for U.S. manufacturing and R&D facilities. What if it’s not accurate? Greg Slabodkin Read by Brittany Duncan https://www.pharmamanufacturing.com/editors-review/article/55314470/editors-review-it-matters-if-big-pharma-is-fudging-its-us-investment-numbers

Episode metadata supplied by the publisher feed · Published Sep 16, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Editor’s (re)View: It matters if Big Pharma is fudging its US investment numbers

0:00 4:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off Script: A Pharma Manufacturing Podcast?

This episode is 4 minutes long.

When was this Off Script: A Pharma Manufacturing Podcast episode published?

This episode was published on September 16, 2025.

Can I download this Off Script: A Pharma Manufacturing Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!